Top compounds associated with response to LRFN2


Feature Type Standardized
Nominal ANOVA
mRNA momelotinib CTRPv2 pan-cancer AAC -0.028 0.4
mRNA paclitaxel CCLE pan-cancer AAC 0.036 0.4
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.029 0.4
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.037 0.4
mRNA skepinone-L CTRPv2 pan-cancer AAC 0.042 0.4
mRNA EX-527 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA BMS-754807 GDSC1000 pan-cancer AAC -0.028 0.4
mRNA C6-ceramide CTRPv2 pan-cancer AAC 0.03 0.4
mRNA Imatinib CTRPv2 pan-cancer AAC -0.029 0.4
Download CSV